Mr. Elahi has over 20 years of investment banking experience, with a focus on merger and acquisition advisory services in the healthcare services industry. Mr. Elahi’s advisory experience spans a broad spectrum of sectors including acute care, specialty inpatient, managed care, alternate site providers, diagnostic laboratories and imaging, long-term care, rehabilitation and staffing.
Prior to rejoining Dresner Partners, Mr. Elahi held multiple executive advisory positions. As a Managing Director at BDO USA, LLP, PwC’s Health Industries, and Deloitte, Mr. Elahi focused on a range of solutions for Provider, Payer, and Life Sciences from M&A, growth strategy, partnerships, competitiveness and transformation. Previous to these roles, Mr. Elahi spent over six years at Dresner Partners where he developed the firm’s Healthcare Advisory Practice and worked with a range of leading healthcare institutions including Walgreens and Carle Foundation Hospital.
Mr. Elahi founded Life Sciences Group, a diagnostic imaging joint venture with a physician group, and spent four years at Ponder & Co. where he co-established the firm’s healthcare services mergers and acquisitions practice. Previous to Ponder, he spent six years as an mergers and acquisitions banker, initially with Citicorp and Salomon Smith Barney in New York, where he focused on the Utilities and Energy industries, and subsequently with ABN AMRO Incorporated in Chicago, where his primary role was transaction management in the healthcare industry. Mr. Elahi has been involved in a variety of domestic and cross-border mergers and acquisitions transactions, including the $1.1 billion sale of the 14-hospital Health Midwest system to HCA.